期刊文献+

氧化海藻酸钠交联改性脱细胞基质材料及其细胞相容性研究 被引量:2

Study on Preparation of Acellular Matrix Material Fixed by Oxidized Sodium Alginate and Its Cytocompatibility
原文传递
导出
摘要 运用高碘酸钠氧化法制备新型的生物交联剂—氧化海藻酸钠(ADA)并将之用于交联改性脱细胞基质材料,通过检测一些交联指标及交联后材料的性能特征来研究ADA交联改性脱细胞基质材料的特点。实验中采用了目前典型的两类交联剂(戊二醛(GA)和京尼平(GP))作为实验对照组。用三种交联剂处理血管组织15min~72h,测定交联过程中的交联指数,并对彻底交联后材料的力学性能以及细胞相容性进行研究。结果表明,ADA交联脱细胞基质材料的交联速率、交联程度不亚于GA,明显优于GP;交联后的材料也具有更适宜的力学性能;在细胞相容性方面,ADA交联的材料也具有明显优于GA、与GP相当的这样非常理想的效果。综上所述,ADA是一种具有很大发展前景的生物组织交联剂。 This study was intended to investigate the crosslinking characteristics of a new crosslinking agent--oxidized sodium alginate (ADA), which might provide an ideal biological crosslinking reagent for the construction of soft tissue bioprostheses. Glutaraldehyde and genipin, which have been typically used in developing bioprostheses, were used as controls. The porcine aortas were treated by these three crosslinking agents for 15 rain to 72 h and the fixation index was determined. Subsequently, the mechanical property and cytocompatibility of fixed tissues were al- so tested. The results indicated that fixed tissues by ADA were comparable as glutaraldehyde and superior to genipin controls in fixative efficiency. It was also found that tissues fixed by ADA were comparable as genipin and superior to glutaraldehyde controls in cytocompatibility and were similar to natural tissues in mechanical property. The results of in vitro study demonstrated that ADA could be a promising crosslinking reagent for biological tissue fixation.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2011年第6期1154-1158,共5页 Journal of Biomedical Engineering
基金 四川省卫生厅科研课题资助(100194)
关键词 氧化海藻酸钠 生物组织 交联指数 力学性能 细胞相容性 Oxidized sodium alginate (ADA) Biological tissues Fixation index Mechanical properties Cytocompatibility
  • 相关文献

参考文献20

  • 1李沁华.组织工程天然生物材料支架的特征[J].中国临床康复,2006,10(29):144-145. 被引量:2
  • 2TEEBKEN O E, HAVERICH A. Tissue engineering of small diameter vascular grafts [J]. Eur J Vase Endovase Surg, 2002, 23: 474-485.
  • 3张生来.PC预处理异体生物材料的应用前景[J].上海生物医学工程,1999,20(2):54-56. 被引量:4
  • 4LE-TIEN C, MILLETTE M, LACROIX M, et al. Modified alginate matrices for the immobilization of bioactive agents [J]. Biotechnol Appl Biochem, 2004, 39(Pt2) :189-198.
  • 5SCHMIDT C E, BAIER J M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering [J]. Biomaterials, 2000, 21(22) : 2215- 2231.
  • 6SUNG H W, SHIH J S, HSU C S, et al. Crosslinking characteristics of porcine tendons: Effects of fixation with glutaraldehyde or epoxy [J]. J Biomed Mater Res, 1996, 30(3): 361-367.
  • 7NISHI C, NAKAJIMA N, IKADA Y, et al. In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification [J]. J Biomed Mater Res, 1995,29 (7) : 829- 834.
  • 8余喜讯,成敏,陈槐卿.改造天然生物组织为血管支架材料的预处理方法[J].生物医学工程学杂志,2004,21(3):476-481. 被引量:23
  • 9DUMITRIU S. Polysaccharides as biomaterials. In polymeric biomaterials [M]. New York, 2002: 1.
  • 10UENG S W, LEE S S, LIN S S, et al. Biodegradable alginate antibiotic beads [J]. Clin-Orthop Relat Res, 2000, 380:250-259.

二级参考文献62

共引文献42

同被引文献82

  • 1程庆甦,王硕,李秋鸿,陈婧,刘华青,穆畅道.双醛淀粉/胶原共混膜的制备及性能研究[J].皮革科学与工程,2010,20(6):8-12. 被引量:10
  • 2Fisher MB, Mauck RL. Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng Part B Rev, 2013, 19(1): 1-13.
  • 3O'Brien FJ. Biomaterials & scaffolds for tissue engineering. Materials Today, 2011, 14(3): 88-95.
  • 4Tian L, George SC. Biomaterials to prevascularize engineered tissues. J Cardiovasc Transl Res, 2011, 4(5): 685-698.
  • 5Zeugolis DI, Paul GR, Attenburrow G. Cross-linking of extruded col- lagen fibers-a biomimetic three-dimensional scaffold for tissue engi- neering applications. J Biomed Mater Res A, 2009, 89(4): 895-908.
  • 6He L, Mu C, Shi J, et al. Modification of collagen with a natural cross- linker, procyanidin. Int J Biol Macromol, 2011, 48(2): 354-359.
  • 7Lti X, Zhai W, Zhou Y, et al. Crosslinking effect of Nordihydroguai- aretic acid (NDGA) on decellularized heart valve scaffold for tissue engineering. J Mater Sci Mater Med, 2010, 21(2): 473-480.
  • 8Koch H, Graneist C, Emmrich F, et al. Xenogenic esophagus scaffolds fixed with several agents: comparative in vivo study of rejection and inflammation. J Biomed Biotechnol, 2012, 2012: 948320.
  • 9Lii JM, Nurko J, Weakley SM, et al. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit, 2010, 16(5): RA93-100.
  • 10Yang C, Xu L, Zhou Y, et al. A green fabrication approach of gelatin/ CM-chitosan hybrid hydrogel for wound healing. Carbohydrate Poly- mers, 2010, 82(4): 1297-1305.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部